{"id":14147,"date":"2011-07-11T00:00:00","date_gmt":"2011-07-10T21:00:00","guid":{"rendered":"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/"},"modified":"2011-07-11T00:00:00","modified_gmt":"2011-07-10T21:00:00","slug":"sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine","status":"publish","type":"post","link":"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/","title":{"rendered":"Sanitas: Clearance received from the Antimonopoly Committee of Ukraine"},"content":{"rendered":"\n<p>Reference is made to the public releases of 24th May 2011 announcing that <em>Valeant Pharmaceuticals International, Inc.<\/em> (&#8220;<em>Valeant&#8221;<\/em>) intends to acquire the entire 87.2% shareholding from the funds advised by <em>Citi Venture Capital International <\/em>(&#8220;<em>CVCI&#8221;<\/em>, through the legal entities <em>Citigroup Venture Capital International Jersey Limited<\/em> and <em>Baltic Pharma Limited<\/em>), <em>AB Invalda<\/em> (\u201c<em>Invalda<\/em>\u201d), <em>Amber Trust II S.C.A.<\/em> (\u201c<em>Amber<\/em>\u201d) and certain other persons (together the \u201cControlling Shareholders\u201d) and, following such acquisition, to launch a mandatory takeover offer to acquire the remaining shares in AB <em>Sanitas<\/em> from the minority shareholders (more information is available at: <a href=\"http:\/\/www.sanitasgroup.com\/index.php\/news\/news\/the-signature-date-of-the-share-sale-and-purchase-agreement-has-been-corrected\/11468\">http:\/\/www.sanitasgroup.com\/index.php\/news\/news\/the-signature-date-of-the-share-sale-and-purchase-agreement-has-been-corrected\/11468<\/a>) and 10th June 2011 regarding the submission of the notification about the proposed transaction to the Antimonopoly Committee of Ukraine (more information is available at: <a href=\"http:\/\/www.sanitasgroup.com\/index.php\/news\/news\/notification-of-the-proposed-transaction-to-a-competition-authority\/11483\">http:\/\/www.sanitasgroup.com\/index.php\/news\/news\/notification-of-the-proposed-transaction-to-a-competition-authority\/11483<\/a>).<\/p>\n<p>Today, 11th July 2011, AB <em>Sanitas<\/em> announces that <em>Valeant<\/em> has received a decision from the <em>Antimonopoly Committee of Ukraine<\/em> approving <em>Valeant\u2019s<\/em> intended acquisition without imposing any conditions. <\/p>\n<p>Clearance from the <em>Competition Council of the Republic of Lithuania<\/em> and the <em>Polish Office for Competition and Consumer Protection<\/em> is still pending.<\/p>\n<p>A further announcement will be made when appropriate.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Reference is made to the public releases of 24th May 2011 announcing that Valeant Pharmaceuticals International, Inc. (&#8220;Valeant&#8221;) intends to acquire the entire 87.2% shareholding from the funds advised by..<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[14],"tags":[6],"class_list":["post-14147","post","type-post","status-publish","format-standard","hentry","category-group-company-press-releases","tag-imported"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sanitas: Clearance received from the Antimonopoly Committee of Ukraine - Invalda INVL<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sanitas: Clearance received from the Antimonopoly Committee of Ukraine - Invalda INVL\" \/>\n<meta property=\"og:description\" content=\"Reference is made to the public releases of 24th May 2011 announcing that Valeant Pharmaceuticals International, Inc. (&#8220;Valeant&#8221;) intends to acquire the entire 87.2% shareholding from the funds advised by..\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/\" \/>\n<meta property=\"og:site_name\" content=\"Invalda INVL\" \/>\n<meta property=\"article:published_time\" content=\"2011-07-10T21:00:00+00:00\" \/>\n<meta name=\"author\" content=\"wkd\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"wkd\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/\"},\"author\":{\"name\":\"wkd\",\"@id\":\"https:\/\/www.invaldainvl.com\/#\/schema\/person\/46ab7fa082fd2b7cc7794f370fb41424\"},\"headline\":\"Sanitas: Clearance received from the Antimonopoly Committee of Ukraine\",\"datePublished\":\"2011-07-10T21:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/\"},\"wordCount\":200,\"commentCount\":0,\"keywords\":[\"Imported\"],\"articleSection\":[\"Group company press releases\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/\",\"url\":\"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/\",\"name\":\"Sanitas: Clearance received from the Antimonopoly Committee of Ukraine - Invalda INVL\",\"isPartOf\":{\"@id\":\"https:\/\/www.invaldainvl.com\/#website\"},\"datePublished\":\"2011-07-10T21:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/www.invaldainvl.com\/#\/schema\/person\/46ab7fa082fd2b7cc7794f370fb41424\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.invaldainvl.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sanitas: Clearance received from the Antimonopoly Committee of Ukraine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.invaldainvl.com\/#website\",\"url\":\"https:\/\/www.invaldainvl.com\/\",\"name\":\"Invalda INVL\",\"description\":\"Invalda INVL\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.invaldainvl.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.invaldainvl.com\/#\/schema\/person\/46ab7fa082fd2b7cc7794f370fb41424\",\"name\":\"wkd\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.invaldainvl.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6edb7b2b6ec752de6b92ee190810a20be9cc6219f961b7fe5053c63dcf92c4a8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6edb7b2b6ec752de6b92ee190810a20be9cc6219f961b7fe5053c63dcf92c4a8?s=96&d=mm&r=g\",\"caption\":\"wkd\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sanitas: Clearance received from the Antimonopoly Committee of Ukraine - Invalda INVL","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/","og_locale":"en_US","og_type":"article","og_title":"Sanitas: Clearance received from the Antimonopoly Committee of Ukraine - Invalda INVL","og_description":"Reference is made to the public releases of 24th May 2011 announcing that Valeant Pharmaceuticals International, Inc. (&#8220;Valeant&#8221;) intends to acquire the entire 87.2% shareholding from the funds advised by..","og_url":"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/","og_site_name":"Invalda INVL","article_published_time":"2011-07-10T21:00:00+00:00","author":"wkd","twitter_card":"summary_large_image","twitter_misc":{"Written by":"wkd","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/#article","isPartOf":{"@id":"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/"},"author":{"name":"wkd","@id":"https:\/\/www.invaldainvl.com\/#\/schema\/person\/46ab7fa082fd2b7cc7794f370fb41424"},"headline":"Sanitas: Clearance received from the Antimonopoly Committee of Ukraine","datePublished":"2011-07-10T21:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/"},"wordCount":200,"commentCount":0,"keywords":["Imported"],"articleSection":["Group company press releases"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/","url":"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/","name":"Sanitas: Clearance received from the Antimonopoly Committee of Ukraine - Invalda INVL","isPartOf":{"@id":"https:\/\/www.invaldainvl.com\/#website"},"datePublished":"2011-07-10T21:00:00+00:00","author":{"@id":"https:\/\/www.invaldainvl.com\/#\/schema\/person\/46ab7fa082fd2b7cc7794f370fb41424"},"breadcrumb":{"@id":"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.invaldainvl.com\/group-company-press-releases\/sanitas-clearance-received-from-the-antimonopoly-committee-of-ukraine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.invaldainvl.com\/en\/"},{"@type":"ListItem","position":2,"name":"Sanitas: Clearance received from the Antimonopoly Committee of Ukraine"}]},{"@type":"WebSite","@id":"https:\/\/www.invaldainvl.com\/#website","url":"https:\/\/www.invaldainvl.com\/","name":"Invalda INVL","description":"Invalda INVL","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.invaldainvl.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.invaldainvl.com\/#\/schema\/person\/46ab7fa082fd2b7cc7794f370fb41424","name":"wkd","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.invaldainvl.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/6edb7b2b6ec752de6b92ee190810a20be9cc6219f961b7fe5053c63dcf92c4a8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6edb7b2b6ec752de6b92ee190810a20be9cc6219f961b7fe5053c63dcf92c4a8?s=96&d=mm&r=g","caption":"wkd"}}]}},"_links":{"self":[{"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/posts\/14147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/comments?post=14147"}],"version-history":[{"count":0,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/posts\/14147\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/media?parent=14147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/categories?post=14147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/tags?post=14147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}